Literature DB >> 26261592

Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.

Bing Li1, Yilin Wang2, Shiting Li3, Hua He4, Fengbin Sun3, Chunlin Wang5, Yicheng Lu4, Xiaoqiang Wang3, Bangbao Tao3.   

Abstract

microRNAs (miRNAs) are a class of small non-coding RNAs that play important roles in a variety of biological process. It has been reported that dysregulation of miRNA is always associated with cancer progression and development, and miR-378 aberrant expression has been found in some types of cancers. However, the association of miR-378 and glioma has not been evaluated. In this work, we measured the expression of miR-378 in glioma tissues and non-neoplastic brain tissues was measured using real-time PCR, and found that miRNA-378 expression level was significantly lower in glioma tissues compared with non-neoplastic brain tissues. Patients with lower miR-378 expression level had significantly poorer overall survival. Multivariate Cox regression analysis showed that miR-378 expression was an independent prognostic factor for 5-year overall survival. Over-expression of miR-378 inhibits glioma cell migration and invasion. In conclusion, our results indicated that miR-378 may serve as a tumor suppressor and play an important role in inhibiting tumor migration and invasion. Our work implicates the potential effect of miR-378 on the prognosis of glioma.

Entities:  

Keywords:  cell migration and invasion; glioma; miR-378; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26261592      PMCID: PMC4525926     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.

Authors:  John K Chan; Tuyen K Kiet; Kevin Blansit; Rashmi Ramasubbaiah; Joan F Hilton; Daniel S Kapp; Daniela Matei
Journal:  Gynecol Oncol       Date:  2014-03-25       Impact factor: 5.482

2.  MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues.

Authors:  Aihua Liu; Michael T Tetzlaff; Pat Vanbelle; David Elder; Michael Feldman; John W Tobias; Antonia R Sepulveda; Xiaowei Xu
Journal:  Int J Clin Exp Pathol       Date:  2009-03-20

3.  Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Authors:  Santosh K Patnaik; Eric Kannisto; Steen Knudsen; Sai Yendamuri
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

4.  Diffuse brainstem glioma: prognostic factors.

Authors:  Marcos Dellaretti; Nicolas Reyns; Gustavo Touzet; François Dubois; Sebastião Gusmão; Júlio Leonardo Barbosa Pereira; Serge Blond
Journal:  J Neurosurg       Date:  2012-08-31       Impact factor: 5.115

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

Review 7.  The 2007 WHO classification of tumors of the central nervous system - what has changed?

Authors:  Audrey Rousseau; Karima Mokhtari; Charles Duyckaerts
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

Review 8.  Incorporation of prognostic and predictive factors into glioma clinical trials.

Authors:  Derek R Johnson; Evanthia Galanis
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

9.  Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.

Authors:  Zheng-sheng Wu; Chao-qun Wang; Ru Xiang; Xue Liu; Shan Ye; Xue-qing Yang; Gui-hong Zhang; Xiao-chun Xu; Tao Zhu; Qiang Wu
Journal:  BMC Cancer       Date:  2012-02-01       Impact factor: 4.430

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  23 in total

1.  MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.

Authors:  Wende Li; Yujiao Liu; Weining Yang; Xiaoxing Han; Sen Li; Hao Liu; Leo E Gerweck; Dai Fukumura; Jay S Loeffler; Burton B Yang; Rakesh K Jain; Peigen Huang
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

2.  MicroRNA Alterations in Induced Pluripotent Stem Cell-Derived Neurons from Bipolar Disorder Patients: Pathways Involved in Neuronal Differentiation, Axon Guidance, and Plasticity.

Authors:  Monica Bame; Melvin G McInnis; K Sue O'Shea
Journal:  Stem Cells Dev       Date:  2020-06-17       Impact factor: 3.272

3.  Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.

Authors:  Weiwei Gong; Caixia Zhu; Yueyang Liu; Alexander Muckenhuber; Holger Bronger; Andreas Scorilas; Marion Kiechle; Julia Dorn; Viktor Magdolen; Tobias Dreyer
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

4.  Prognostic value of microRNA-378 in esophageal cancer and its regulatory effect on tumor progression.

Authors:  Wei Jin; Lixin Wang; Sujie Cheng; Hongmei Lv
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

5.  Overexpression of miR-378 Alleviates Chronic Sciatic Nerve Injury by Targeting EZH2.

Authors:  Pengfei Gao; Xin Zeng; Lin Zhang; Long Wang; Lu-Lu Shen; Ya-Yun Hou; Fang Zhou; Xianlong Zhang
Journal:  Neurochem Res       Date:  2021-08-18       Impact factor: 3.996

6.  Glioblastoma-Astrocyte Connexin 43 Gap Junctions Promote Tumor Invasion.

Authors:  Sean McCutcheon; David C Spray
Journal:  Mol Cancer Res       Date:  2021-10-15       Impact factor: 6.333

7.  The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions.

Authors:  Shengya Tian; Yang Cao; Jinliang Wang; Yongjun Bi; Jingquan Zhong; Xiangbin Meng; Wenyu Sun; Ruixue Yang; Luping Gan; Xuping Wang; Hongshi Li; Rong Wang
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

8.  Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu).

Authors:  Kai Nan; Yuankai Zhang; Xin Zhang; Dong Li; Yan Zhao; Zhaopu Jing; Kang Liu; Donglong Shang; Zilong Geng; Lihong Fan
Journal:  Stem Cell Res Ther       Date:  2021-06-07       Impact factor: 6.832

9.  Differential Expression Profiles of Mitogenome Associated MicroRNAs Among Colorectal Adenomatous Polyps.

Authors:  LaShanale Wallace; Karen Aikhionbare; Saswati Banerjee; Katie Peagler; Mareena Pitts; Xuebiao Yao; Felix Aikhionbare
Journal:  Cancer Res J (N Y N Y)       Date:  2021-01-25

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.